Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

I Want You Back: Putting The Patient Into Policy

This article was originally published in Scrip

Executive Summary

Time was when the patient barely got a look in where drug development was concerned. Pharma firms would identify a new substance with therapeutic potential in a disease like breast cancer or hypertension, develop a drug and get it approved. Patients were at the receiving end and had little or no say in how the drug was conceived, developed and evaluated. The regulators themselves had little idea of the impact their decisions and policies had on patients' everyday lives.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

SC063967

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel